title: [The balance of markers of regulation vascular tone and fibrinogen in the prognosis of hemorrhagic transformation and fatal outcome in the acute period of ischemic stroke].
abstract: The markers of regulation vascular tone, such as rennin, endothelin-1, and C-type natriuretic peptide, are of great value for prognosis of hemorrhagic transformation and fatal outcome of ischemic stroke. A change in the vascular tone in case of hemorrhagic transformation at the affected site precedes activation of the coagulation component of hemostasis as a mechanism preventing blood loss and increasing fibrinogen level. This work was aimed to study the balance of the above markers and fibrinogen in the prognosis of hemorrhagic transformation and fatal outcome in the acute period of ischemic stroke. It included 62 patients receiving no thrombolytic therapy. It was shown that symptomatic hemorrhagic transformation was associated with elevated rennin levels without a marked fall in the level of C-type natriuretic peptide and asymptomatic hemorrhagic transformation with elevated endothelin-1 levels and decreased concentration of natriuretic peptide. Fibrinogen level on day 4 of the observation proved to be a reliable predictor of negative prognosis. Asymptomatic hemorrhagic transformation without fatal outcome was associated with systemic and local vasoconstriction and inhibition of local vasodilation. Symptomatic hemorrhagic transformation with the fatal outcome was accompanied by dysregulation of vascular tone in the form of activation of systemic and local vasoconstriction, insufficient inhibition of local vasodilation and compensatory reaction in the form of activation of hemostatic mechanisms manifest as elevated fibrinogen levels on day 4. The lethal outcome without hemorrhagic transformation was associated with systemic vasoconstriction, activation of local vasodilation and vasoconstriction leading to local "biochemical paralysis" of vascular tone regulation.
authors.forename: O V
authors.initials: OV
authors.lastname: Liang
authors.forename: A G
authors.initials: AG
authors.lastname: Kochetov
authors.forename: A A
authors.initials: AA
authors.lastname: Arkhipkin
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Novozhenova
authors.forename: N A
authors.initials: NA
authors.lastname: Shamalov
authors.forename: G R
authors.initials: GR
authors.lastname: Ramazanov
authors.forename: M R
authors.initials: MR
authors.lastname: Chuĭko
authors.forename: P P
authors.initials: PP
authors.lastname: Ogurtsov
authors.forename: V I
authors.initials: VI
authors.lastname: Skvortsova
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D002545:Brain Ischemia / Q000150:complications*; D002543:Cerebral Hemorrhage / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D012085:Chymosin / Q000097:blood*; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D020098:Natriuretic Peptide, C-Type / Q000097:blood*; D011237:Predictive Value of Tests; D011379:Prognosis; D020521:Stroke / Q000209:etiology / Q000378:metabolism / Q000401:mortality / Q000503:physiopathology; D016019:Survival Analysis; D014666:Vasomotor System / Q000378:metabolism / Q000503:physiopathology
chemical_list: D015415:Biomarkers; D019332:Endothelin-1; D020098:Natriuretic Peptide, C-Type; D005340:Fibrinogen; D012085:Chymosin